Designed for Consistency and Control
Advanced Therapy Bioreactor (ATB™) is ABEC’s closed, automated single-use bioreactor system designed to support sensitive, perfusion-driven advanced therapy processes. ATB delivers the control, reproducibility, and confidence required to move cell therapy and gene therapy programs forward—without unnecessary complexity.
PROVEN TO DELIVER
REPEATABLE PERFORMANCE
Advanced therapy manufacturing introduces new challenges: sensitive cell lines, tight control windows, and high variability risk. ATB was designed to address those challenges directly, applying ABEC’s proven engineering to earlier-phase and emerging therapy workflows.
ATB delivers closed, automated operation with reliable, repeatable performance—providing a clear path from development through scale-out and future growth. It’s advanced therapy manufacturing with confidence built in.
PROCESS SENSITIVITY
ABEC’s ATB systems are designed to protect fragile cell cultures through controlled mixing, precise gas transfer, and stable process conditions. Automation and closed operation help reduce variability while maintaining repeatability, run after run.
CLOSED-SYSTEM CONTROL
ATB’s fully closed automated workflows reduce contamination risk, operator variability, and manual intervention—supporting consistent outcomes in demanding advanced therapy environments.
BUILT TO SCALE
ATB provides a standardized, repeatable platform that enables scale-out strategies and future integration into hybrid or larger-scale ABEC solutions, including stainless steel. As programs mature, ATB fits naturally into broader facility strategies.
FAST DEPLOYMENT
ATB is designed for efficient installation, validation, and operation—helping teams move from development into production readiness without any unnecessary delays or redesign.
BACKED BY A FULL ECOSYSTEM
ATB maximizes ABEC’s broader capabilities in process sciences, automation, Hybrid BioProcessing, and lifecycle services—ensuring performance is supported not just at installation, but as processes evolve. ATB isn’t a standalone solution—it’s part of a proven ecosystem.
